HSR&D Research Career Scientist Award
高铁
基本信息
- 批准号:10535424
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-10-01 至 2025-09-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdmission activityAntibioticsAntimicrobial ResistanceAreaAustraliaAwardBiometryCanadaCaringCathetersChinaChronicCollaborationsCommunicable DiseasesComplexCountryDiscipline of NursingDiseaseDoctor of PhilosophyEngineeringEpidemiologistEpidemiologyFranceGermanyGoalsGovernmentGuidelinesHealth ServicesHealthcareHomogeneously Staining RegionHospitalizationInfectionInfection ControlJournalsMaster of ScienceMedical centerMedicineMentorsMethodologyMethodsMissionMonitorMorbidity - disease rateMulti-Drug ResistanceNetherlandsOutcomePaperPatient CarePatientsPeer ReviewPersonsPoliciesPopulationPreventionPrincipal InvestigatorPublicationsPublishingRegistriesResearchResearch ActivityResearch DesignResearch PersonnelResearch SupportRisk FactorsScienceScientistServicesSourceSpainSpinal CordSpinal cord injuryStatistical Data InterpretationStudentsSwitzerlandTechniquesTechnologyTrainingUnited KingdomUnited StatesUniversitiesVeteransWorkcareercompare effectivenessdata warehousehealthcare-associated infectionshigh riskimplementation scienceimprovedinfection managementinfection riskinnovationmembermethicillin resistant Staphylococcus aureusmodifiable riskmortalitymulti-drug resistant pathogenmultidisciplinarypatient populationprogramsresearch studystudent mentoringtooltreatment and outcomeurinary
项目摘要
I have been conducting research in health services, epidemiology, and implementation science at the Hines
VA Medical Center, HSR&D Center of Innovation for Complex Chronic Healthcare (CINCCH) for over 19
years. My primary area of research has focused on Veterans with SCI/D, whom are at increased risk for
infections and acquiring multidrug resistant organisms (MDROs). Little research had been conducted in this
patient population, particularly in the VA which is the single largest source of care for persons with SCI/D in
the U.S. My research has made significant impacts on the care of Veterans with SCI/D. This includes
developing and disseminating a toolkit on prevention of methicillin-resistant Staphylococcus aureus (MRSA)
colonization/infection for patients with SCI/D; educating clinicians about the modifiable risk factors of
MDROs and impacts on morbidity and mortality in this population, and working collaboratively with clinicians
and investigators across the country to develop tools for monitoring and tracking outcomes in Veterans with
SCI/D, including the new VHA SCI/D outcomes registry. I have also expanded this work to a broader VA
population including leading a QUERI program on antimicrobial resistance. Overall, this portfolio of research
has led to 119 publications (45 first/senior author) and national prestige as a recipient of the Presidential
Early Career Award for Scientists and Engineers (PECASE) in 2012, awarded by the United States
president and White House Office of Science and Technology Policy. In addition, as a doctoral level
epidemiologist, my methodological training has allowed me to support the research activities of
collaborators across the country. I also conduct mentoring activities for both clinician and non-clinician
investigators, fellows, and students and participate in service activities for both VA and non-VA workgroups
and committees. This award will be used to: 1) conduct and disseminate research that improves the health
care and outcomes of Veterans, with a particular focus on prevention and management of infections and
MDROs; 2) support the quantitative training and mentoring of students, fellows, and early career
investigators; and 3) provide service to local and national committees to support the mission of VA, the
HSR&D program, and CINCCH.
我一直在进行研究,在卫生服务,流行病学,和实施科学在海因斯
VA医疗中心,HSR&D复杂慢性医疗保健创新中心(CINCCH),
年我的主要研究领域集中在SCI/D退伍军人,他们的风险增加,
感染和获得多药耐药微生物(MDRO)。在这方面,
患者人群,特别是在VA,这是SCI/D患者的最大单一护理来源,
我的研究对SCI/D退伍军人的护理产生了重大影响。这包括
开发和传播预防耐甲氧西林金黄色葡萄球菌的工具包
SCI/D患者的定植/感染;教育临床医生关于
MDRO及其对该人群发病率和死亡率的影响,并与临床医生合作
和全国各地的调查人员开发工具,用于监测和跟踪退伍军人的结果,
SCI/D,包括新的VHA SCI/D结局登记。我还将这项工作扩展到更广泛的VA
包括领导一个关于抗菌素耐药性的QUERI项目。总的来说,这份研究报告
已导致119出版物(45第一/资深作者)和国家声望作为总统的收件人
2012年美国科学家和工程师早期职业奖(PECASE)
总统和白宫科技政策办公室。此外,作为博士级别的
作为一名流行病学家,我的方法学训练使我能够支持以下研究活动:
全国各地的合作者。我还为临床医生和非临床医生开展指导活动
研究人员,研究员和学生,并参加VA和非VA工作组的服务活动
和委员会。该奖项将用于:1)开展和传播改善健康的研究
护理和退伍军人的成果,特别注重预防和管理感染,
MDRO; 2)支持学生、研究员和早期职业的定量培训和指导
调查员; 3)向地方和国家委员会提供服务,以支持退伍军人事务部的使命,
HSR&D计划和CINCCH。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHARLESNIKA T EVANS其他文献
CHARLESNIKA T EVANS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHARLESNIKA T EVANS', 18)}}的其他基金
Dissemination and Implementation of a Videoconference Antimicrobial Stewardship Team (VAST)
视频会议抗菌管理团队 (VAST) 的传播和实施
- 批准号:
10672768 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Dissemination and Implementation of a Videoconference Antimicrobial Stewardship Team (VAST)
视频会议抗菌管理团队 (VAST) 的传播和实施
- 批准号:
10620614 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Dissemination and Implementation of a Videoconference Antimicrobial Stewardship Team (VAST)
视频会议抗菌管理团队 (VAST) 的传播和实施
- 批准号:
10312278 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Combating Antimicrobial Resistance through Rapid Implementation of Available Guidelines and Evidence (CARRIAGE)
通过快速实施现有指南和证据来对抗抗菌素耐药性 (CARRIAGE)
- 批准号:
10187395 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Effectiveness of Treatment and Outcomes for Veterans Infected with Resistant Gram-negative Organisms.
感染耐药革兰氏阴性菌的退伍军人的治疗效果和结果。
- 批准号:
10186505 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Effectiveness of Treatment and Outcomes for Veterans Infected with Resistant Gram-negative Organisms.
感染耐药革兰氏阴性菌的退伍军人的治疗效果和结果。
- 批准号:
9502631 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Effectiveness of Treatment and Outcomes for Veterans Infected with Resistant Gram-negative Organisms.
感染耐药革兰氏阴性菌的退伍军人的治疗效果和结果。
- 批准号:
9695865 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Combating Antimicrobial Resistance through Rapid Implementation of Available Guidelines and Evidence (CARRIAGE)
通过快速实施现有指南和证据来对抗抗菌素耐药性 (CARRIAGE)
- 批准号:
9205309 - 财政年份:2016
- 资助金额:
-- - 项目类别:
Combating Antimicrobial Resistance through Rapid Implementation of Available Guidelines and Evidence (CARRIAGE)
通过快速实施现有指南和证据来对抗抗菌素耐药性 (CARRIAGE)
- 批准号:
10200821 - 财政年份:2016
- 资助金额:
-- - 项目类别:














{{item.name}}会员




